EMaBS TB Vaccine Study

NCT03681860 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Safety
Immunogenicity

Interventions

BIOLOGICAL: ChAdOx185A
BIOLOGICAL: MVA85A
BIOLOGICAL: BCG

Sponsor

University of Oxford

Collaborators

[object Object]